FDA questions Amgen drug for prostate cancer
The FDA will ask a panel of outside experts whether the benefits of Amgen's Xgeva outweigh its risks, which included bone disease. (Source: USATODAY.com Health)
Resources dedicated to treatment of mental health
Links and resources dedicated to the understanding and treatment of mental health. (Source: CTV Health)div id=medwormpbiMedWorm Message:/i/b Register forba href=http://www.medmatcha.com target =_selfMedMatcha, MedWorm's medical advertising network/a/b, and receive $5 free advertising./p/div